Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
Lancet
    July 2021
  1. AFIFI T, Obeid M, Abdelati M, Almoqaid A, et al
    WHO/International Society of Hypertension risk prediction charts versus the UK Prospective Diabetes Study risk engine for cardiovascular risk assessment among patients with type 2 diabetes: a comparative study.
    Lancet. 2021;398 Suppl 1:S3.
    >> Share

  2. EL-QATRAWI KJ
    Effect of hypertension on pregnancy outcomes at UNRWA health centres in Gaza governorates: a comparative study.
    Lancet. 2021;398 Suppl 1:S26.
    >> Share

    May 2021
  3. BROUWERS S, Sudano I, Kokubo Y, Sulaica EM, et al
    Arterial hypertension.
    Lancet. 2021 May 18. pii: S0140-6736(21)00221.
    >> Share

  4. AZIZI M, Sanghvi K, Saxena M, Gosse P, et al
    Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00788.
    >> Share

  5. KAHAN T
    Decisions about antihypertensive treatment should focus on reducing cardiovascular risk.
    Lancet. 2021;397:1598-1599.
    >> Share


  6. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
    Lancet. 2021;397:1625-1636.
    >> Share

    August 2020
  7. SCHWALM JD, McCready T, Islam S, McKee M, et al
    Cardiovascular risk in hypertension: open questions about HOPE 4 - Authors' reply.
    Lancet. 2020;396:310-311.
    >> Share

  8. RICHARDS A
    Cardiovascular risk in hypertension: open questions about HOPE 4.
    Lancet. 2020;396:310.
    >> Share

  9. HENDRIKS M, van Andel J, Asiki G, Kyobutungi C, et al
    Cardiovascular risk in hypertension: open questions about HOPE 4.
    Lancet. 2020;396:309-310.
    >> Share

  10. O'SULLIVAN ED, MacIntyre IM
    Individual patient risk assessment and cost-benefit analysis of patiromer in AMBER.
    Lancet. 2020;396:311.
    >> Share

    July 2020
  11. CLUVER CA, Herbst P, Griffith-Richards S, Hassan M, et al
    Coarctation of the aorta: a rare cause of severe hypertension in pregnancy.
    Lancet. 2020;396:62.
    >> Share

  12. REGAN J
    Collaborating on kidneys: Haiti's transplantation ambitions.
    Lancet. 2020;396:15-16.
    >> Share

    June 2020
  13. STRONGMAN H, Lyon AR, Dos Santos Silva I, Smeeth L, et al
    Cancer and cardiovascular disease - Authors' reply.
    Lancet. 2020;395:1904-1905.
    >> Share

  14. AHMED MA, Abdelnabi M, Almaghraby A, Elkafrawy FR, et al
    Neuropathy, encephalopathy, status epilepticus, and acute intermittent porphyria.
    Lancet. 2020;395:e101.
    >> Share

    May 2020
  15. WILLIAMS B, Zhang Y
    Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19.
    Lancet. 2020 May 14. pii: S0140-6736(20)31131.
    >> Share

    March 2020
  16. BOHM M, Kario K, Kandzari DE, Mahfoud F, et al
    Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.
    Lancet. 2020 Mar 27. pii: S0140-6736(20)30554.
    >> Share

  17. HERRETT E, Jackson R, Smeeth L
    Managing cardiovascular disease risk in hypertension - Authors' reply.
    Lancet. 2020;395:870.
    >> Share

  18. MCMANUS R, Constanti M, Floyd CN, Glover M, et al
    Managing cardiovascular disease risk in hypertension.
    Lancet. 2020;395:869-870.
    >> Share

  19. ZHOU F, Yu T, Du R, Fan G, et al
    Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30566.
    >> Share

    November 2019
  20. IVES CW, Oparil S
    What is the first choice for blood pressure treatment?
    Lancet. 2019;394:1782-1784.
    >> Share

    October 2019
  21. GANESAN C, Pao AC
    Spironolactone plus patiromer: proceed with caution.
    Lancet. 2019;394:1486-1488.
    >> Share

  22. THE LANCET
    Where next for randomised controlled trials in global health?
    Lancet. 2019;394:1481.
    >> Share

  23. SUCHARD MA, Schuemie MJ, Krumholz HM, You SC, et al
    Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
    Lancet. 2019 Oct 24. pii: S0140-6736(19)32317.
    >> Share

    September 2019
  24. ZHOU M, Wang H, Zeng X, Yin P, et al
    Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2019;394:1145-1158.
    >> Share

  25. AGARWAL R, Rossignol P, Romero A, Garza D, et al
    Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2019 Sep 13. pii: S0140-6736(19)32135.
    >> Share

  26. THE LANCET
    NICE hypertension guidelines: a pragmatic compromise.
    Lancet. 2019;394:806.
    >> Share

  27. YUSUF S, Joseph P, Rangarajan S, Islam S, et al
    Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
    Lancet. 2019 Sep 2. pii: S0140-6736(19)32008.
    >> Share

    August 2019
  28. SCHWALM JD, McCready T, Lopez-Jaramillo P, Yusoff K, et al
    A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.
    Lancet. 2019 Aug 30. pii: S0140-6736(19)31949.
    >> Share

  29. JAFAR TH, Samad Z, Bloomfield GS
    Parallel community solutions for cardiovascular risk reduction.
    Lancet. 2019 Aug 30. pii: S0140-6736(19)31995.
    >> Share

  30. THE LANCET
    Is the concept of hypertension as a disease unhelpful?
    Lancet. 2019;394:611.
    >> Share

  31. CHOW CK, Gupta R
    Blood pressure control: a challenge to global health systems.
    Lancet. 2019;394:613-615.
    >> Share

  32. LEMOINE ER, Karumanchi SA
    Oral regimen management of acute hypertension in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31717.
    >> Share

  33. EASTERLING T, Mundle S, Bracken H, Parvekar S, et al
    Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31282.
    >> Share

    July 2019
  34. KAHAN T
    Strategies to identify patients for antihypertensive treatment.
    Lancet. 2019 Jul 25. pii: S0140-6736(19)31665.
    >> Share

  35. HERRETT E, Gadd S, Jackson R, Bhaskaran K, et al
    Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study.
    Lancet. 2019 Jul 25. pii: S0140-6736(19)31359.
    >> Share

  36. GELDSETZER P, Manne-Goehler J, Marcus ME, Ebert C, et al
    The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults.
    Lancet. 2019 Jul 18. pii: S0140-6736(19)30955.
    >> Share


  37. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys.
    Lancet. 2019 Jul 18. pii: S0140-6736(19)31145.
    >> Share

  38. BENJAMIN IJ, Kreutz R, Olsen MH, Schutte AE, et al
    Fixed-dose combination antihypertensive medications.
    Lancet. 2019 Jul 15. pii: S0140-6736(19)31629.
    >> Share

    May 2019
  39. FUDIM M, Ali-Ahmed F, Patel MR, Sobotka PA, et al
    Sham trials: benefits and risks for cardiovascular research and patients.
    Lancet. 2019;393:2104-2106.
    >> Share

    April 2019
  40. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
    Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
    >> Share

    March 2019
  41. MENTE A, O'Donnell MJ, Yusuf S
    Urinary sodium excretion measures and health outcomes - Authors' reply.
    Lancet. 2019;393:1295-1296.
    >> Share

  42. VILLANUEVA C, Albillos A, Genesca J, Garcia-Pagan JC, et al
    beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)31875.
    >> Share

  43. GAZZARD G, Konstantakopoulou E, Garway-Heath D, Garg A, et al
    Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
    Lancet. 2019 Mar 8. pii: S0140-6736(18)32213.
    >> Share

    February 2019

  44. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
    Lancet. 2019 Feb 5. pii: S0140-6736(19)30194.
    >> Share

    December 2018
  45. YOUSEFIFARD M, Hosseini M
    Should the cutoff for hypertension in older adults be different from younger adults?
    Lancet. 2018;392:2438-2439.
    >> Share

    November 2018
  46. OLIVA-DAMASO N, Costa-Fernandez J, Oliva-Damaso E, Bravo-Marques R, et al
    Kidneys are key in secondary hypertension: a case of fibromuscular dysplasia.
    Lancet. 2018;392:2298.
    >> Share

    October 2018
  47. LU J, Lu Y, Krumholz HM, Jiang L, et al
    Prevalence and control of hypertension - Authors' reply.
    Lancet. 2018;392:1306.
    >> Share

  48. BOVET P, Chiolero A
    Prevalence and control of hypertension.
    Lancet. 2018;392:1305-1306.
    >> Share

  49. CORDONNIER C, Demchuk A, Ziai W, Anderson CS, et al
    Intracerebral haemorrhage: current approaches to acute management.
    Lancet. 2018;392:1257-1268.
    >> Share

    September 2018
  50. OPARIL S, Fu RH
    Revisiting ASCOT 16 years later.
    Lancet. 2018;392:1092-1094.
    >> Share

  51. KISHORE SP, Salam A, Rodgers A, Jaffe MG, et al
    Fixed-dose combinations for hypertension.
    Lancet. 2018;392:819-820.
    >> Share

    August 2018
  52. GUPTA A, Mackay J, Whitehouse A, Godec T, et al
    Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31776.
    >> Share

    July 2018
  53. HE FJ, Zhang P, Li Y, MacGregor GA, et al
    Action on Salt China.
    Lancet. 2018;392:7-9.
    >> Share

    June 2018
  54. KJELDSEN SE, Esler MD
    Take a blood pressure pill or undergo renal denervation?
    Lancet. 2018;391:2298-2300.
    >> Share

    May 2018
  55. BLANKESTIJN PJ, Bots ML
    Renal denervation in uncontrolled hypertension: the story continues to unfold.
    Lancet. 2018 May 22. pii: S0140-6736(18)31112.
    >> Share

  56. AZIZI M, Schmieder RE, Mahfoud F, Weber MA, et al
    Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
    Lancet. 2018 May 22. pii: S0140-6736(18)31082.
    >> Share

  57. KANDZARI DE, Bohm M, Mahfoud F, Townsend RR, et al
    Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
    Lancet. 2018 May 22. pii: S0140-6736(18)30951.
    >> Share

    February 2018
  58. RIETZSCHEL ER, De Buyzere ML
    Hypertension: time for doctors to switch the driver's seat?
    Lancet. 2018 Feb 27. pii: S0140-6736(18)30317.
    >> Share

  59. MCMANUS RJ, Mant J, Franssen M, Nickless A, et al
    Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial.
    Lancet. 2018 Feb 27. pii: S0140-6736(18)30309.
    >> Share

    January 2018
  60. CHAKER L, Bianco AC, Jonklaas J, Peeters RP, et al
    Hypothyroidism and hypertension: fact or myth? - Authors' reply.
    Lancet. 2018;391:30.
    >> Share

  61. HOFSTETTER L, Messerli FH
    Hypothyroidism and hypertension: fact or myth?
    Lancet. 2018;391:29-30.
    >> Share

    October 2017
  62. SU M, Zhang Q, Bai X, Wu C, et al
    Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey.
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32476.
    >> Share

  63. HESKETH T, Zhou X
    Hypertension in China: the gap between policy and practice.
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32743.
    >> Share

  64. LU J, Lu Y, Wang X, Li X, et al
    Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project).
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32478.
    >> Share

    September 2017
  65. SPIERING W, Williams B, Van der Heyden J, van Kleef M, et al
    Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32337.
    >> Share

  66. COURAND PY, Lantelme P
    Stretching the carotid sinus to treat resistant hypertension.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32298.
    >> Share

    August 2017
  67. AZIZI M
    Catheter-based renal denervation for treatment of hypertension.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32293.
    >> Share

  68. TOWNSEND RR, Mahfoud F, Kandzari DE, Kario K, et al
    Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32281.
    >> Share

    July 2017
  69. RODGERS A, Chow CK, Thakkar J, Bennett A, et al
    A personalised or procrustean approach to treating hypertension? - Authors' reply.
    Lancet. 2017;390:27-28.
    >> Share

  70. GABB GM, Mol PGM, Arnolda LF
    A personalised or procrustean approach to treating hypertension?
    Lancet. 2017;390:26-27.
    >> Share

    June 2017
  71. MUNDLE S, Bracken H, Khedikar V, Mulik J, et al
    Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31367.
    >> Share

  72. SURI V, Sikka P
    Oral misoprostol for induction of labour in hypertensive pregnancies.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31453.
    >> Share

    April 2017
  73. VIDAL-PETIOT E, Bhatt DL, Fox KM, Steg PG, et al
    Blood pressure and cardiovascular outcomes: a closer look - Authors' reply.
    Lancet. 2017;389:1296-1297.
    >> Share

  74. WALD NJ, Wald DS
    Blood pressure and cardiovascular outcomes: a closer look.
    Lancet. 2017;389:1296.
    >> Share

  75. DOUMAS M, Stavropoulos KV, Boutari C, Imprialos KP, et al
    Blood pressure and cardiovascular outcomes: a closer look.
    Lancet. 2017;389:1295-1296.
    >> Share

    December 2016
  76. SLIWA K
    The heart of Africa: succeeding against the odds.
    Lancet. 2016;388:e28-e36.
    >> Share

    October 2016
  77. MENTE A, O'Donnell MJ, Yusuf S
    Sodium and cardiovascular disease - Authors' reply.
    Lancet. 2016;388:2113-2114.
    >> Share

  78. CAPPUCCIO FP
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2112.
    >> Share

  79. KATZ J
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2112-2113.
    >> Share

  80. STRAZZULLO P, Giampaoli S, Iacoviello L, Rossi L, et al
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2111.
    >> Share

  81. WALD N, Law M
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2111-2112.
    >> Share

  82. ALDERMAN MH
    Dietary sodium: paradigm shifts from public health to clinical medicine.
    Lancet. 2016;388:2110.
    >> Share

    August 2016
  83. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
    Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016